BIOMAT Database Logo BIOMAT Database Logo

Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community. 2013

Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin

UI MeSH Term Description Entries
D008297 Male Males
D012111 Residence Characteristics Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services. Community,Domicile,Living Arrangements,Neighborhood,Place of Birth,Residential Selection,Arrangement, Living,Birth Place,Communities,Domiciles,Living Arrangement,Neighborhoods,Residence Characteristic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005346 Fibroblast Growth Factors A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family. DNA Synthesis Factor,Fibroblast Growth Factor,Fibroblast Growth Regulatory Factor,Growth Factor, Fibroblast,Growth Factors, Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone.
August 2012, American journal of physiology. Renal physiology,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
November 2013, Clinical journal of the American Society of Nephrology : CJASN,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.
January 2013, Kidney international,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
November 2014, Atherosclerosis,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast growth factor 23, cardiovascular disease, and inflammation.
July 2012, Clinical journal of the American Society of Nephrology : CJASN,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
August 2021, Journal of the American Heart Association,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast growth factor-23 and cardiovascular events in CKD.
February 2014, Journal of the American Society of Nephrology : JASN,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
January 2014, International urology and nephrology,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study.
February 2016, Journal of the American Geriatrics Society,
Supawat Ratanapo, and Narat Srivali, and Wonngarm Kittanamongkolchai, and Napat Leeaphorn, and Saeed Ahmed, and Wisit Cheungpasitporn, and Daych Chongnarungsin
Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.
October 2017, American journal of physiology. Renal physiology,
Copied contents to your clipboard!